Does RISANKIZUMAB-RZAA Cause Dermatitis contact? 42 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Dermatitis contact have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
42
Reports of Dermatitis contact with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Dermatitis contact From RISANKIZUMAB-RZAA?
Of the 42 reports, 6 (14.3%) required hospitalization.
Is Dermatitis contact Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Dermatitis contact?
TREPROSTINIL (1,834)
DUPILUMAB (358)
HUMAN IMMUNOGLOBULIN G (345)
ADALIMUMAB (321)
EPOPROSTENOL (190)
ETANERCEPT (170)
NICOTINE (163)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (160)
AMBRISENTAN (147)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (146)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Dermatitis contact Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA